Native egg parasitoids recorded from the invasive <Emphasis Type="Italic">Halyomorpha halys</Emphasis> successfully exploit volatiles emitted by the plant–herbivore complex

When an accidentally introduced pest establishes in the invaded area, native natural enemies may adapt to the new host. A decade after the accidental introduction of the brown marmorated stink bug, Halyomorpha halys, in Europe, two generalist native egg parasitoids, the eupelmid Anastatus bifasciatus and the encyrtid Ooencyrtus telenomicida, have been recorded from this invasive agricultural pest in the field. Both species are able to complete development to the adult stage within the new host. Trissolcus basalis (Platygastridae = Scelionidae), which is not associated with H. halys in the field, was reared from freeze-killed sentinel eggs placed on soybean plants in central Italy. We tested in a Y-tube olfactometer the behavioural responses of these egg parasitoids to volatiles from H. halys adults and from Vicia faba plants attacked by H. halys. Both A. bifasciatus and O. telenomicida positively responded to adult H. halys male volatiles and to H. halys-induced plant volatiles, indicating ability to exploit cues associated with the new host for egg location, whereas T. basalis only reacted to female volatiles. A. bifasciatus and O. telenomicida are generalist egg parasitoids, showing a much wider host range when compared to T. basalis. On the other hand, platygastrid egg parasitoids from the native area of H. halys, considered for classical biological control, may be too risky due to the possibility of attacking non-target species, including predaceous stink bugs. Therefore, indigenous A. bifasciatus and O. telenomicida are presently under evaluation for augmentative biological control of H. halys in Europe.     

The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs

Twenty-two dogs with idiopathic epilepsy which were pharmacoresistant to phenobarbitone and bromide were treated with levetiracetam as an add-on medication. Records of eight dogs were used retrospectively to determine a safe, efficient levetiracetam dosage. Fourteen dogs were entered into a prospective, open label, non-comparative study. After 2 months of levetiracetam oral treatment (10 mg/kg TID), 8/14 dogs responded significantly to the treatment and seizure frequency was reduced by 50%. In dogs that remained refractory, the dosage was increased to 20 mg/kg TID for 2 months. One further dog responded to levetiracetam treatment. Levetiracetam responders had a significant decrease in seizure frequency of 77% (7.9+/-5.2 to 1.8+/-1.7 seizures/month) and a decrease in seizure days per month of 68% (3.8+/-1.7 to 1.2+/-1.1 seizure days/month). However, 6/9 responders experienced an increase in seizure frequency and seizure days after 4-8 months continuing with the levetiracetam treatment at the last effective dosage. Levetiracetam was well tolerated by all dogs and sedation was the only side-effect reported in just one of the 14 dogs.